? Eculizumab, complement inhibitor in severe COVID19
Apr 29, 2020•9 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
? Eculizumab, complement inhibitor in severe COVID19 | Dr RR Baliga's 'Got Knowledge Doc?' Podkasts for Physicians |
Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? | Circulation https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.120.047419#.XqjUc7YNhYU.twitter
Not Medical Advice or Opinion
For the best experience, listen in Metacast app for iOS or Android